NCT00001155View on ClinicalTrials.gov

Treatment of Wegener's Granulomatosis With Cyclophosphamide

PHASE2CompletedINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

February 29, 1976

Study Completion Date

February 28, 2002

Conditions

VasculitisWegener's Granulomatosis

Interventions

DRUG

cyclophosphamide

Trial Locations (1)

20892

National Institute of Allergy and Infectious Diseases (NIAID), Bethesda

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH